Oral Progesterone for Prevention of Miscarriage in Threatened Abortion
NCT04788108
Abortion, Threatened, Female Urogenital Diseases and Pregnancy Complications
Bangkok, Thailand
View Trial DetailsNCT Number: NCT02686112
The study aims to quantify the relations between first & second trimester bleeding and maternal & neonatal morbidity. Additionally, the study will help in assessing the risk for abortions in women with threatened abortions and the risk factors for threatened abortion.
Looking for future studies?
Notify MeFemale
Observational
the study is following woman retrospectively through their pregnancy from the first trimester troughout delivery .
we will measure the relation between first and/or second trimester bleeding ( threatend abortion ) and pregnancy outcome ( as written below ) - maternal and neonatal .
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 9 months
by using our data in the past 7 years we will examine retrospectively cases of patients from their first admission due to vaginal bleeding throgh their pregnancy and labor .
the mesearment will include : Intra uterine growth retardation , Antepartum hemorrhage, premature rupture of membrane, Intra uterine fetal death , Preterm delivery, Apgar less than 7, Congenital malformation, Mode of delivery - vaginal delivery vs. cesarean section
Bnai Zion Medical Center
Other Gov
Acronym: POTA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04788108
Abortion, Threatened, Female Urogenital Diseases and Pregnancy Complications
Bangkok, Thailand
View Trial DetailsNCT03930212
Abortion, Threatened, Female Urogenital Diseases and Pregnancy Complications
Tanta, Egypt
View Trial DetailsNCT02420769
Abortion, Threatened, Female Urogenital Diseases and Pregnancy Complications
Cairo, Egypt
View Trial DetailsNCT07357922
Abortion, Threatened, Female Urogenital Diseases and Pregnancy Complications
View Trial Details